About: breast cancer
Fighting metastatic breast cancer is a race against time in Poland
Ewa Myślińska is a 29-year-old patient who has been fighting cancer for four years now. She remembers it was 9 October when she touched her breast incidentally and felt a strange hardness. EURACTIV Poland reports.
Italian patients with advanced breast cancer in search of information
Despite efforts to raise awareness by the authorities, patients with metastatic breast cancer in Italy are still struggling to understand what options they have and often lose precious time trying to identify the latest available treatments.
Germany frontrunner for metastatic breast cancer drug approvals, with some hiccups
While the German healthcare system is at Europe's forefront in terms of making drugs available for the treatment of metastatic breast cancer, problems still arise as some important drugs have been withdrawn from the market.
France leads Europe in care for metastatic breast cancer patients, but not in screening
Although France is seen as a "leader" in organising the care of women with metastatic cancer, as their quality of life has become an essential aspect of patient care in France, screening - which can reduce mortality by 20% - must be stepped up. EURACTIV France reports.
Health Commissioner: EU cancer plan must ‘break the silence’ on women’s cancers
There is a large inequality of access to women's cancer services and treatments across the block, according to the EU health chief, who highlighted the role of Europe's Beating Cancer plan in bridging these disparities.
How patients’ involvement brings quality to cancer care and policymaking
Medical experts and stakeholders from patient advocacy groups are keen to point out how crucial it is to consider patients’ voice as an added value when conducting cancer clinical trials, whatever policy on cancer, national or EU-wide, will eventually be put together.
Health expert: Cancer control plans must be implemented
The governments should take full responsibility for the implementation of national cancer plans, which are a commitment toward people and not just a piece of paper, health expert Dr Tit Albreht told EURACTIV.com in an interview.
Better access to health innovation is Kyriakides’ top priority (and hardest task)
With increased powers, Health Commissioner-designate Stella Kyriakides is tasked with striking a difficult balance between making sure there is a steady supply of affordable medicines and ensuring that EU pharma industry remains a world leader in innovation.
Thousands of breast cancer patients can avoid chemotherapy, landmark study says
Chemotherapy may be avoided in about 70% of early-stage breast cancer patients, thus limiting chemotherapy to the 30% who can be predicted it will be beneficial for them, a study released on Sunday (3 June) shows.
Time to address the EU’s inequalities in breast cancer diagnosis and care
Across the EU, we have seen positive results for breast cancer care as more women are being diagnosed and treated earlier, leading to higher survival rates. However, while the EU as a whole is making advancement, progress is not consistent across its territory, writes Cristian Silviu Bușoi.
MEPs step up action to protect terminally ill workers in the EU
A group of EU lawmakers has taken the UK-led “Dying to Work” campaign to the EU in an effort to mobilise support for terminally ill patients across Europe, who face unfair treatment at work.
Empower cancer patients to improve quality of life, say experts
A group of metastatic breast cancer experts has urged policymakers to empower patients with greater choice and participation in their treatment and care, to improve the quality of life of patients, their carers and families.
EU lawmakers push for better outcomes for metastatic breast cancer patients
Metastatic breast cancer (MBC) kills half a million women in the EU every year, yet progress on the quality of life and survival time of MBC patients remains elusive. MEPs addressed the need to improve patient outcomes with a policy roadmap launched on Tuesday (17 October).
EU agency OK’d 39 cancer drugs without evidence they work, study shows
The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).
Closing the gap on metastatic breast cancer
October is breast cancer awareness month. The pink ribbon movement has achieved progress in spreading awareness and pushing for widespread cancer screening.
Breast implant victims win payout from German safety body
A French court on Friday ordered German safety certifier TUV to pay €60 million in compensation to 20,000 women who received defective breast implants that the group had approved.
Andriukaitis: We have the tools to avoid ‘unnecessary loss of lives’
Decision-makers should stop ignoring risk factors like tobacco, which causes deaths that could have been avoided, Health Commissioner Vytenis Andriukaitis told EURACTIV.com. VideoPromoted content
Health and safety at work: Priorities and gender challenges
ETUI Senior Researcher Aida Ponce talks to ETUC Confederal Secretary Esther Lynch about the priorities and gender challenges that employees face at their workplace.
Getting Europe Moving
A new study shows the costs of ‘doing nothing’: the inactivity time bomb is killing 500,000 Europeans, and costing over € 80 billion per year. ISCA (International Sport & Culture Association) is campaignin to get 100 million Europeans to move more by 2020. Read the full report and find out what you can do to help get Europe moving at http://inactivity-time-bomb.nowwemove.com.
High cholesterol causes breast cancer, study shows
British researchers have discovered a relationship between high cholesterol levels in women, and breast cancer. EURACTIV France reports.